AirAvant Medical is proud to announce that its flagship product, FDA Cleared Bongo Rx, is now available for patients requiring treatment of mild to moderate obstructive sleep apnea (OSA).
Years of painstaking research, development, and testing have yielded a device that is small, portable, and best of all requires no CPAP machine, CPAP hoses, bulky headgear or electricity/battery power. The Bongo Rx seals comfortably in the nose and works by creating back pressure when an OSA sufferer exhales.
After extensive clinical testing, it was demonstrated the Bongo Rx significantly reduced the Apnea-Hypopnea Index or AHI levels, which is the measurement for the number of apneas and hypopneas recorded per hour of sleep. AirAvant Medical developed the Bongo Rx to be convenient and transportable. Its small size allows the user to carry it in a shirt pocket or purse so the device can be used anywhere at any time.
“We recognize that people need to have the ability to treat their sleep apnea comfortably and conveniently, no matter where they are – in a bed, on a train, on a plane, or even catching a quick nap in a chair or on the couch,” said Javier Collazo, Vice-President. “For compliant CPAP patients, the Bongo Rx may provide a supplemental treatment option to complement their lifestyle. For non-compliant CPAP patients, the Bongo Rx may provide a patient-friendly, non-cumbersome treatment option to get them refocused and re-engaged on treating their obstructive sleep apnea.